The results of the antigen tests in the Opportunity Passport will be available from August. Until then, the Centre of Registers is to renew the form for retrieving such data.
According to the adviser to the minister of healthcare, Asta Riukienė, talks are underway with the state-owned company to speed up the process.
As the minister’s office said, at present it is not possible for the results of antibody tests to be included in the document. It is not technically possible to compile the data.
In mid-May, Vice Minister of Economy and Innovation Vincas Jurgutis announced that this possibility would appear in June.
Currently, for those recovered from the virus, the Opportunity Passport is valid for 180 days from the time of diagnosis, while for vaccinated persons there is no fixed date.
The document can be obtained by a person who is one week after the second dose of “BioNTech”, “Pfizer” or Moderna, 2 weeks after vaccination with “Johnson & Johnson” and 4 weeks after the first dose of AstraZeneca.
Two more cases of the Brazilian coronavirus strain have been detected in Lithuania.
According to the Ministry of Healthcare, one of the cases may be related to the town of Bezdonys in the Vilnius region, therefore its inhabitants will be tested for the presence of COVID-19.
A mobile testing point will be open in Bezdonys on Friday and Saturday. All townspeople are encouraged to be examined, including those who do not have symptoms of the coronavirus. It will be possible to come to the research without registration.
The collected samples will be tested for the sequence of the coronavirus genome.
So far, 4 cases of the Brazilian coronavirus have been detected in Lithuania.
According to epidemiologists, recently there has been a high incidence of COVID-19 in Bezdonys. In May, the infection was confirmed in 26 people, in April, 25 cases of the virus were recorded.
Experts do not rule out that the Brazilian variant of the coronavirus may have contributed to this.
On Wednesday, the 6th delivery of the vaccine by the pharmaceutical company Janssen Pharmaceutica NV, 7,200 doses, arrived in Lithuania. So far, Lithuania has received 36,000 doses of this manufacturer’s vaccine. According to the Ministry of Healthcare, 17.4 thousand were used.
Vaccines are to be distributed taking into account non-approved residents from priority groups. Also, the municipalities with the highest incidence of the coronavirus are to receive more vaccines.
So far, 1 million 34 thousand people, or 37 per cent of the population, have been vaccinated with one or two doses.